Skip to main content

Formula IV Plus - New , NeoLife International Pty Ltd, CON-1032

Product name
Formula IV Plus - New
Sponsor name
NeoLife International Pty Ltd
Consent start
Consent no.
CON-1032
Standard
TGO 92 Standard for labels of non-prescription medicines - subparagraphs 10(8)(a)(vi) and 10(8)(a)(vii) of Therapeutic Goods Order No. 92 - Standard for labels of non-prescription medicines
Non-compliance with standard
The product does not comply because the individual unit wrapper (intermediate packaging) does not include the names and quantities of all active ingredients in the medicine.
Conditions imposed
The outer carton (primary packaging) must include a statement indicating that each individually wrapped unit must be kept inside the carton prior to the time of consumption. The Company may choose the following statements on your labels or wordings along those lines. 'Do not remove from primary packaging before use'; or 'Store in original outer packaging until use'
Therapeutic product type
Listed complementary medicines

Help us improve the Therapeutic Goods Administration site